Literature DB >> 1531227

Antiproliferative activity of the non-myelotoxic antitumour agent of plant origin, Thaliblastine, on two human glioma cell lines.

D K Todorov1, W J Zeller.   

Abstract

The antiproliferative activity of the non-myelotoxic antitumour agent of plant origin, Thaliblastine, on two human glioma cell lines is described. Thaliblastine was added once one day following start of culture; proliferation was monitored over 7 days. The antiproliferative activity of Thaliblastine was strongly dependent on concentration and time of incubation. The ID50 of Thaliblastine in T406 and GW27 glioma lines was 5.1 micrograms/ml and 8.2 micrograms/ml (7.0 microM and 11.2 microM), respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531227     DOI: 10.1007/bf01187497

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Phase I study of thalicarpine (NAC-68075), a plant alkaloid of noval structure.

Authors:  P J Creaven; M H Cohen; O S Selawry; F Tejada; L E Broder
Journal:  Cancer Chemother Rep       Date:  1975 Sep-Oct

2.  Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).

Authors:  L M Allen; P J Creaven
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

3.  Cytotoxic effect of alkaloids from Thalictrum minus ssp. elatum and their derivatives.

Authors:  N M Mollov; H B Dutschewska; K Siljanovska; S Stojcev
Journal:  C R Acad Bulg Sci       Date:  1968

4.  Incorporation of the antitumor alkaloid thaliblastine in liposomes enhances its cytotoxic activity in vitro.

Authors:  D K Todorov; G Deliconstantinos
Journal:  Experientia       Date:  1982-07-15

5.  Establishment and characterization of human glioblastoma cell lines in vitro and their xenografts in nude mice.

Authors:  H Fischer; W J Zeller; K Schwechheimer; K J Hutter; B Wowra; S Kunze; V Sturm
Journal:  Onkologie       Date:  1989-08

6.  THALICTRUM ALKALOIDS. I. THALICARPINE, A NEW HYPOTENSIVE ALKALOID FROM THALICTRUM DASYCARPUM.

Authors:  S M KUPCHAN; K K CHAKRAVARTI; N YOKOYAMA
Journal:  J Pharm Sci       Date:  1963-10       Impact factor: 3.534

Review 7.  Chemotherapy for malignant gliomas.

Authors:  P L Kornblith; M Walker
Journal:  J Neurosurg       Date:  1988-01       Impact factor: 5.115

8.  Interaction of 99mTc-labeled liposomes with Walker tumour cells in vitro. Liposome-mediated introduction of thaliblastine into resistant Walker tumour cells.

Authors:  G Deliconstantinos; G Ramantanis; D K Todorou
Journal:  Gen Pharmacol       Date:  1983

9.  Effect of thaliblastine on transplantable tumours in mice.

Authors:  J Mircheva; J Stoychkov
Journal:  Biomedicine       Date:  1976-09-30

10.  Thalicarpine (NSC-68075): plasma decay and urinary excretion in man.

Authors:  P J Creaven; L M Allen
Journal:  Cancer Treat Rep       Date:  1976-01
View more
  2 in total

1.  Cell cycle effects of thaliblastine.

Authors:  F Seifert; D K Todorov; K J Hutter; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Antiproliferative activity of liposomal epirubicin on experimental human gliomas in vitro and in vivo after intratumoral/interstitial application.

Authors:  D K Todorov; S S Ninjo; W J Zeller
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.